September 29, 2017 – “As the country considers ways to once again reform its healthcare system, we have to remember that competition among insurance companies can become so confusing as to bewilder patients and physicians, thereby thwarting their ability to get affordable treatments for people with serious illnesses like rheumatoid arthritis. When it comes to consumer choice, more is not always better, especially when the products – the insurance plans – available to consumers are as inscrutable as a James Joyce novel.”
To read this article from Peter Ubel, click here.